Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.
Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition. EMBO Rep. 2017 09; 18(9):1671.
View in:
PubMed
authors with profiles
Deric Park